Result: Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma

*Title*:

*Author/editor-in-chief*:

*Publication*:

Freiburg : Universität, 2022

*Physical description scale*:

1 Online-Ressource

*Format*:

*eBook*

*Language*:

*eng*

*Notes*:

ESMO open. - 7, 4 (2022) , 100520, ISSN: 2059-7029

*DOI*:

10.1016/j.esmoop.2022.100520

*Result*: Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma